An interventional study of global care in Elderly, Medication Reconciliation and Patient Readmission, sponsored by Lille Catholic University. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2026-04-20.
Sponsored by Lille Catholic University · Not applicable, Interventional, and Prevention
This study evaluates the impact of optimizing drug prescriptions on re-admissions of elderly patients within 30 days after hospital discharge. It compares a group of patients receiving comprehensive care (medication reconciliation at hospital entry, multidisciplinary medication review, and medication reconciliation at discharge), versus another group that does not benefit from the program.
Lille Catholic University is the lead sponsor of 111 studies on the registry; 26 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Standard healthcare procedures
medical reconciliation at admission, multidisciplinary medication review, medical reconciliation at discharge of the hospital
Other: global care
Medication Reconciliation at admission, Multidisciplinary medication review, Medication Reconciliation at discharge
Rate of readmission at 30 days
Evaluate the impact of optimizing drug prescriptions on re-admissions of elderly patients within 30 days of return to home.Only direct re-admissions to emergency and geriatric short-stay services in participating centres will be counted.
Time frame: 30 days
Time between discharge and first readmission
Evaluate the impact of medication management on the time required for the first re-admission to hospital, if it takes place before 30 days.
Time frame: 30 days
Rate of changes in the prescription after hospital discharge by the general practitioner
Estimate the impact of this process on the preservation of the prescription after hospital discharge by general practitioner within the 30 days following the return home actual number of discrepancies, what may have caused the change and which are the concerned drugs
Time frame: 30 days
Identification of Seniors at Risk (ISAR) score
This score is based on 6 yes/no questions. T e total scale range is from 0 to 6. Each item is scored 1 if there is a problem or 0 if there is not, being the maximum score =6.
Time frame: 30 days
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lille Catholic University